Standard of practice: Endovascular treatment of intracranial atherosclerosis

Journal of NeuroInterventional Surgery

Volumn 4, Issue 6, 2012, Pages 397-406

  Hussain, M Shazam ^a   Fraser, Justin F ^b   Abruzzo, Todd ^c   Blackham, Kristine A ^d   Bulsara, Ketan R ^e   Derdeyn, Colin P ^f   Gandhi, Chirag D ^g   Hirsch, Joshua A ^h   Hsu, Daniel P ⁱ   Jayaraman, Mahesh V ^j   Meyers, Philip M ^k   Narayanan, Sandra ^l   Prestigiacomo, Charles J ^m   Rasmussen, Peter A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BARNES JEWISH HOSPITAL   (United States)

^g NEUROLOGICAL INSTITUTE OF NEW JERSEY   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^j BROWN UNIVERSITY   (United States)

^k NEUROLOGICAL INSTITUTE   (United States)

^l WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; NITINOL; PACLITAXEL; ROSUVASTATIN; WARFARIN;

ARTICLE; BARE METAL STENT; BRAIN ATHEROSCLEROSIS; CARDIOTOXICITY; CAROTID ANGIOPLASTY; CAROTID ARTERY STENTING; DRUG ELUTING STENT; DRUG FATALITY; EVIDENCE BASED MEDICINE; EXTRAINTRACRANIAL ANASTOMOSIS; HEALTH CARE ORGANIZATION; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL STANDARD; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF EXPANDING STENT; TREATMENT OUTCOME;

ANIMALS; ENDOVASCULAR PROCEDURES; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; STANDARD OF CARE; TREATMENT OUTCOME;

EID: 84870913157     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2012-010405     Document Type: Article

References (119)

1. Sacco RL, Kargman DE, Gu Q, et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995;26:14-20.
2. Wong LK. Global burden of intracranial atherosclerosis. Int J Stroke 2006;1:158-9. (Pubitemid 44151508)
3. Chaturvedi S, Turan TN, Lynn MJ, et al . Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology 2007;69:2063-8. (Pubitemid 350175708)
4. Rincon F, Sacco RL, Kranwinkel G, et al. Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis 2009;28:65-71.
5. Bang OY, Kim JW, Lee JH, et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005;65:296-8. (Pubitemid 41022378)
6. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53. (Pubitemid 38579764)
7. Bruce KD, Hanson MA. The developmental origins, mechanisms, and implications of metabolic syndrome. J Nutr 2010;140:648-52.
8. Lee DK, Kim JS, Kwon SU, et al. Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: Early diffusion-weighted imaging study. Stroke 2005;36:2583-8.
9. Derdeyn CP, Powers WJ, Grubb RL Jr. Hemodynamic effects of middle cerebral artery stenosis and occlusion. AJNR Am J Neuroradiol 1998;19:1463-9. (Pubitemid 30431039)
10. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-16.
11. Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555-63.
12. Derdeyn CP, Chimowitz MI. Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N Am 2007;17:355-63, viiieix. (Pubitemid 47362743)
13. Famakin BM, Chimowitz MI, Lynn MJ, et al. Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke 2009;40:1999-2003.
14. Mazighi M, Labreuche J, Gongora-Rivera F, et al. Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke 2008;39:1142-7. (Pubitemid 351440682)
15. Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the gesica study. Neurology 2006;66:1187-91. (Pubitemid 43739702)
16. Derdeyn CP, Grubb RL Jr, Powers WJ. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology 1999;53:251-9. (Pubitemid 29344343)
17. Feldmann E, Wilterdink JL, Kosinski A, et al. The stroke outcomes and neuroimaging of intracranial atherosclerosis (sonia) trial. Neurology 2007;68:2099-106. (Pubitemid 46915385)
18. Sadikin C, Teng MM, Chen TY, et al. The current role of 1.5t non-contrast 3d time-of-flight magnetic resonance angiography to detect intracranial steno-occlusive disease. J Formos Med Assoc 2007;106:691-9. (Pubitemid 47577635)
19. Bash S, Villablanca JP, Jahan R, et al. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol 2005;26:1012-21. (Pubitemid 43821943)
20. Nguyen-Huynh MN, Wintermark M, English J, et al. How accurate is CT angiography in evaluating intracranial atherosclerotic disease? Stroke 2008;39:1184-8. (Pubitemid 351440689)
21. Kim SJ, Seok JM, Bang OY, et al. MR mismatch profiles in patients with intracranial atherosclerotic stroke: a comprehensive approach comparing stroke subtypes. J Cereb Blood Flow Metab 2009;29:1138-45.
22. Ozgur HT, Kent Walsh T, Masaryk A, et al. Correlation of cerebrovascular reserve as measured by acetazolamide-challenged spect with angiographic flow patterns and intra- or extracranial arterial stenosis. AJNR Am J Neuroradiol 2001;22:928-36. (Pubitemid 32436238)
23. Prabhakaran S, Warrior L, Wells KR, et al. The utility of quantitative magnetic resonance angiography in the assessment of intracranial in-stent stenosis. Stroke 2009;40:991-3.
24. Amin-Hanjani S, Alaraj A, Calderon-Arnulphi M, et al. Detection of intracranial instent restenosis using quantitative magnetic resonance angiography. Stroke 2010;41:2534-8.
25. Fifi JT, Meyers PM, Lavine SD, et al. Complications of modern diagnostic cerebral angiography in an academic medical center. J Vasc Interv Radiol 2009;20:442-7.
26. Cloft HJ, Joseph GJ, Dion JE. Risk of cerebral angiography in patients with subarachnoid hemorrhage, cerebral aneurysm, and arteriovenous malformation: a meta-analysis. Stroke 1999;30:317-20. (Pubitemid 29071796)
27. Cloft HJ, Lynn MJ, Feldmann E, et al. Risk of cerebral angiography in patients with symptomatic intracranial atherosclerotic stenosis. Cerebrovasc Dis 2011;31:588-91.
28. Samuels OB, Joseph GJ, Lynn MJ, et al. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000;21:643-6. (Pubitemid 30210425)
29. Schumacher HC, Meyers PM, Higashida RT, et al. Reporting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis. Stroke 2009;40:-348-65.
30. Mori T, Fukuoka M, Kazita K, et al. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 1998;19:1525-33. (Pubitemid 30431049)
31. Meyers PM, Blackham KA, Abruzzo TA, et al. Society of Neurointerventional Surgery standards of practice: general considerations. J Neurointerv Surg 2012;4:11-15.
32. Gibbons RJ, Smith S, Antman E. American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from? Circulation 2003;107:2979-86. (Pubitemid 36736643)
33. Gibbons RJ, Smith SC Jr, Antman E. American College of Cardiology/American Heart Association clinical practice guidelines: part II: evolutionary changes in a continuous quality improvement project. Circulation 2003;107:3101-7. (Pubitemid 36763546)
34. Ocebm Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence . Oxford Centre for Evidence-Based Medicine. http://www.Cebm.Net/index. Aspx?O=5653 (accessed 1 Sep 2011).
35. Edlund W, Gronseth G, So Y, et al. Clinical practice guideline process manual . edn. 2004. http://www.aan.com/globals/axon/assets/2535.pdf (accessed 1 Sep 2011).
36. ACCF/AHA Task Force on Practice Guidelines. Methodologies and policies from the ACCF/AHA task force on practice guidelines. http://assets.cardiosource. com/Methodology-Manual-for-ACC-AHA-Writing-Committees.pdf and http://circ.ahajournals.org/manual/ (accessed 1 Sep 2011).
37. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (match): randomised, double-blind, placebo-controlled trial. Lancet 2004;364:331-7.
38. Anon. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348:1329-39.
39. Halkes PH, van Gijn J, Kappelle LJ, et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006;367:1665-73.
40. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993-1003.
41. Gupta R. Symptomatic intracranial atherosclerotic disease: what is the best treatment option? Stroke 2008;39:1661-2.
42. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure- lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.
43. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (life): a randomised trial against atenolol. Lancet 2002;359:995-1003. (Pubitemid 34286536)
44. Amarenco P, Bogousslavsky J, Callahan A 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-59. (Pubitemid 44202151)
45. Anon. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC bypass study group. N Engl J Med 1985;313:1191-200.
46. Powers WJ, Clarke WR, Grubb RL Jr, et al. Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the carotid occlusion surgery study randomized trial. JAMA 2011;306:1983-92.
47. Yu SC, Leung TW, Lee KT, et al. Angioplasty and stenting of atherosclerotic middle cerebral arteries with wingspan: evaluation of clinical outcome, restenosis, and procedure outcome. AJNR Am J Neuroradiol 2011;32:753-8.
48. Tang CW, Chang FC, Chern CM, et al. Stenting versus medical treatment for severe symptomatic intracranial stenosis. AJNR Am J Neuroradiol 2011;32:911-16.
49. Nguyen TN, Zaidat OO, Gupta R, et al. Balloon angioplasty for intracranial atherosclerotic disease: periprocedural risks and short-term outcomes in a multicenter study. Stroke 2011;42:107-11.
50. Qureshi AI, Tariq N, Hassan AE, et al. Predictors and timing of neurological complications following intracranial angioplasty and/or stent placement. Neurosurgery 2011;68:53-60.
51. Chamczuk AJ, Ogilvy CS, Snyder KV, et al. Elective stenting for intracranial stenosis under conscious sedation. Neurosurgery 2010;67:1189-93.
52. Lanfranconi S, Bersano A, Branca V, et al. Stenting for the treatment of high-grade intracranial stenoses. J Neurol 2010;257:1899-908.
53. Suri MF, Tariq N, Siddiq F, et al. Intracranial angioplasty and/or stent placement in octogenarians is associated with a threefold greater risk of periprocedural stroke or death. J Endovasc Ther 2010;17:314-19.
54. Povedano G, Zuberbuhler P, Lylyk P, et al. Management strategies in posterior circulation intracranial atherosclerotic disease. J Endovasc Ther. 2010;17:308-13.
55. Costalat V, Maldonado IL, Zerlauth JB, et al. Endovascular treatment of symptomatic intracranial arterial stenosis: Six-year experience in a single-center series of 42 consecutive patients with acute and mid-term results. Neurosurgery 2010;67:1505-13.
56. Zhao ZW, Deng JP, He SM, et al. Intracranial angioplasty with Gateway-Wingspan system for symptomatic atherosclerotic stenosis: Preliminary results of 27 chinese patients. Surg Neurol 2009;72:607-11.
57. Kurre W, Berkefeld J, Brassel F, et al. In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses: results from the intrastent multicentric registry. Stroke 2010;41:494-8.
58. Vajda Z, Miloslavski E, Guthe T, et al. Treatment of intracranial atherosclerotic arterial stenoses with a balloon-expandable cobalt chromium stent (Coroflex Blue): procedural safety, efficacy, and midterm patency. Neuroradiology 2010;52:645-51.
59. Blasel S, Yukzek Z, Kurre W, et al. Recanalization results after intracranial stenting of atherosclerotic stenoses. Cardiovasc Intervent Radiol 2010;33:914-20.
60. Samaniego EA, Hetzel S, Thirunarayanan S, et al. Outcome of symptomatic intracranial atherosclerotic disease. Stroke 2009;40:2983-7.
61. Miao ZR, Feng L, Li S, et al. Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: long-term follow-up at a single center. Neurosurgery 2009;64:79-84.
62. Siddiq F, Vazquez G, Memon MZ, et al. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a multicenter study. Stroke 2008;39:2505-10.
63. Kurre W, Berkefeld J, Sitzer M, et al. Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable pharos stent: initial experience. Neuroradiology 2008;50:701-8.
64. Mazighi M, Yadav JS, Abou-Chebl A. Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke 2008;39:1766-9.
65. Suh DC, Kim JK, Choi JW, et al. Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR Am J Neuroradiol 2008;29:781-5. (Pubitemid 351596115)
66. Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology 2008;70:1518-24. (Pubitemid 351589505)
67. Ralea IC, Nighoghossian N, Tahon F, et al. Stenting of symptomatic basilar and vertebral artery stenosis in patients resistant to optimal medical prevention: the Lyon Stroke Unit Experience. Eur Neurol 2008;60:127-31.
68. Puetz V, Gahn G, Becker U, et al. Endovascular therapy of symptomatic intracranial stenosis in patients with impaired regional cerebral blood flow or failure of medical therapy. AJNR Am J Neuroradiol 2008;29:273-80. (Pubitemid 351287880)
69. Freitas JM, Zenteno M, Aburto-Murrieta Y, et al. Intracranial arterial stenting for symptomatic stenoses: a Latin American Experience. Surg Neurol 2007;68:378-86. (Pubitemid 47495938)
70. Fiorella D, Chow MM, Anderson M, et al. A 7-year experience with balloonmounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 2007;61:236-42. (Pubitemid 47357287)
71. Jiang WJ, Xu XT, Jin M, et al . Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results. AJNR Am J Neuroradiol 2007;28:830-4. (Pubitemid 46776056)
72. Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan Study. Stroke 2007;38:1531-7. (Pubitemid 46684170)
73. Jiang WJ, Du B, Leung TW, et al. Symptomatic intracranial stenosis: cerebrovascular complications from elective stent placement. Radiology 2007;243:188-97. (Pubitemid 46579710)
74. Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007;38:881-7. (Pubitemid 46568447)
75. Jiang WJ, Xu XT, Du B, et al . Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology 2007;68:420-6. (Pubitemid 46208744)
76. Turk AS, Ahmed A, Niemann DB, et al. Utilization of self-expanding stents in the treatment of intracranial atherosclerotic disease in the distal small cerebral vessels. Neuroradiology 2007;49:659-63. (Pubitemid 47163355)
77. Steinfort B, Ng PP, Faulder K, et al. Midterm outcomes of Paclitaxel-eluting stents for the treatment of intracranial posterior circulation stenoses. J Neurosurg 2007;106:222-5. (Pubitemid 46203146)
78. Qureshi AI, Kirmani JF, Hussein HM, et al. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery 2006;59:1044-51. (Pubitemid 44852090)
79. Wojak JC, Dunlap DC, Hargrave KR, et al. Intracranial angioplasty and stenting: long-term results from a single center. AJNR Am J Neuroradiol 2006;27:1882-92. (Pubitemid 44556503)
80. Marks MP, Wojak JC, Al-Ali F, et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006;37:1016-20.
81. Gupta R, Al-Ali F, Thomas AJ, et al. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 2006;37:2562-6. (Pubitemid 44454680)
82. Abou-Chebl A, Krieger DW, Bajzer CT, et al. Intracranial angioplasty and stenting in the awake patient. J Neuroimaging 2006;16:216-23. (Pubitemid 44933489)
83. Abou-Chebl A, Bashir Q, Yadav JS. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke 2005;36:-165-8.
84. Boulos AS, Agner C, Deshaies EM. Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease. Neurol Res 2005;27(Suppl 1):S95-102.
85. Lylyk P, Vila JF, Miranda C, et al. Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol Res 2005;27(Suppl 1):S84-8. (Pubitemid 41510936)
86. Henkes H, Miloslavski E, Lowens S, et al. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (wingspan). Neuroradiology 2005;47:222-8. (Pubitemid 40778829)
87. Chow MM, Masaryk TJ, Woo HH, et al. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. AJNR Am J Neuroradiol 2005;26:869-74. (Pubitemid 43079783)
88. Suh DC, Kim SJ, Lee DH, et al. Outcome of endovascular treatment in symptomatic intracranial vascular stenosis. Korean J Radiol 2005;6:1-7. (Pubitemid 40470499)
89. Marks MP, Marcellus ML, Do HM, et al . Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol 2005;26:525-30. (Pubitemid 43085952)
90. Lee TH, Kim DH, Lee BH, et al. Preliminary results of endovascular stent-assisted angioplasty for symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol 2005;26:166-74. (Pubitemid 43079842)
91. Hatano T, Tsukahara T, Ogino E, et al. Stenting for vertebrobasilar artery stenosis. Acta Neurochir Suppl 2005;94:137-41.
92. Kessler IM, Mounayer C, Piotin M, et al. The use of balloon-expandable stents in the management of intracranial arterial diseases: a 5-year single-center experience. AJNR Am J Neuroradiol. 2005;26:2342-8.
93. Kim DJ, Lee BH, Kim DI, et al. Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results. AJNR Am J Neuroradiol 2005;26:1381-8. (Pubitemid 43733434)
94. Qureshi AI, Suri MF, Siddiqui AM, et al. Clinical and angiographic results of dilatation procedures for symptomatic intracranial atherosclerotic disease. J Neuroimaging 2005;15:240-9. (Pubitemid 40863658)
95. Weber W, Mayer TE, Henkes H, et al . Stent-angioplasty of intracranial vertebral and basilar artery stenoses in symptomatic patients. Eur J Radiol 2005;55:231-6. (Pubitemid 40982441)
96. Yu W, Smith WS, Singh V, et al. Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology 2005;64:1055-7. (Pubitemid 40388461)
97. Kim JK, Ahn JY, Lee BH, et al. Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome. J Neurol Neurosurg Psychiatry 2004;75:847-51. (Pubitemid 38658506)
98. Jiang WJ, Wang YJ, Du B, et al. Stenting of symptomatic m1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke 2004;35:1375-80. (Pubitemid 38697461)
99. SSYLVIA Study Investigators. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results. Stroke 2004;35:1388-92.
100. Groschel K, Schnaudigel S, Pilgram SM, et al. A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009;40:-340-7.
101. de Rochemont Rdu M, Turowski B, Buchkremer M, et al. Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stentsdinitial experience. Radiology 2004;231:45-9. (Pubitemid 38375407)
102. Gupta R, Schumacher HC, Mangla S, et al. Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology 2003;61:1729-35. (Pubitemid 38020820)
103. Levy EI, Horowitz MB, Koebbe CJ, et al. Transluminal stent-assisted angiplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery 2001;48:1215-21.
104. Mori T, Kazita K, Chokyu K, et al . Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol 2000;21:249-54. (Pubitemid 30102148)
105. Gomez CR, Misra VK, Liu MW, et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 2000;31:95-9. (Pubitemid 30035759)
106. Leung TW, Kwon SU, Wong KS. Management of patients with symptomatic intracranial atherosclerosis. Int J Stroke 2006;1:20-5. (Pubitemid 43740668)
107. VISSIT Trial. http://clinicaltrials.gov/ct2/show/NCT00816166 (accessed 5 Feb 2012).
108. Fiorella DJ, Levy EI, Turk AS, et al. Target lesion revascularization after wingspan: assessment of safety and durability. Stroke 2009;40:106-10.
109. Turk AS, Levy EI, Albuquerque FC, et al. Influence of patient age and stenosis location on wingspan in-stent restenosis. AJNR Am J Neuroradiol 2008;29:23-7.
110. Nahab F, Lynn MJ, Kasner SE, et al. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 2009;72:2014-19.
111. Chimowitz MI, Lynn MJ, Turan TN, et al. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis 2011;20:357-68.
112. FDA Device Approvals and Clearances: Wingspan Stent System With Gateway PTA Balloon Catheter . http://www.accessdata.fda.gov/cdrh-docs/pdf5/H050001b.pdf (accessed 5 Feb 2012).
113. Fiorella D, Thiabolt L, Albuquerque FC, et al. Antiplatelet therapy in neuroendovascular therapeutics. Neurosurg Clin N Am 2005;16:517-40, vi. (Pubitemid 41766379)
114. Gum PA, Kottke-Marchant K, Welsh PA, et al. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003;41:961-5. (Pubitemid 36315537)
115. Chen WH, Lee PY, Ng W, et al . Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 2004;43:1122-6. (Pubitemid 38353000)
116. Matetzky S, Shenkman B, Guetta V, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004;109:3171-5.
117. Scozzafava J, Hussain MS, Yeo T, et al. Case report: aggressive blood pressure management for carotid endarterectomy hyperperfusion syndrome. Can J Anaesth 2006;53:764-8. (Pubitemid 44420061)
118. Abou-Chebl A, Reginelli J, Bajzer CT, et al. Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting. Catheter Cardiovasc Interv 2007;69:690-6. (Pubitemid 46581258)
119. Blackham KA, Meyers PM, Abruzzo TA, et al. Endovascular therapy of acute ischemic stroke: report of the standards of practice committee of the society of neurointerventional surgery. J Neurointerv Surg 2012;4:87-93.